Press Release
New in crypto investment? Let’s get started with Bit.Store where it only takes 3 steps to get cryptos
Investing in digital currency has become a trend
With the new record Bitcoin (BTC) price reached earlier this year and the wave of price surge of DOGE and SHIB led by Elon Musk, digital currency has gradually attracted outsiders. It has become one of the major topics in global investment trend. Players including Facebook, national-level digital currencies, commercial companies, tournament games, Tesla, etc. have all begun to get involved in digital currencies.
Although BTC has fallen from the highest price of $64,000, in fact, many users’ enthusiasm for BTC or other cryptos has not diminished at all. In the tide of digital currency, insiders may be familiar with the concepts and tricks of DeFi, IDO, GameFi, NFT, etc., but outsiders still have difficulties getting started with even the most basic transaction operation as buying or selling.
According to Trading View’s data: The total market value of cryptocurrencies has risen from US$6,617 million on March 1, 2014 to US$2,101 trillion as of date (August 24, 2021). This shows the rapid development of the digital currency industry. Generally speaking, the simplest investment strategy is to buy mainstream cryptos that have endured the test of time, such as Bitcoin and Ethereum. Although the fluctuations are relatively flat, but the return on investment still exceeds any other investment product on the market.
In addition, advanced players will perform position management, and will test invest in some altcoins on platforms such as Binance, Coinbase, and Huobi. More advanced players will perform lock-up mining and various activities like farming and panic buying etc., but these tricks are extremely difficult for novice users. In this case, a simple, easy-to-use and safe software is demanded with urgence. Therefore, Bit.Store comes to help.
Bit.Store makes it easier to buy digital currency
According to its official briefs, Bit.Store is a purchase platform of digital assets with the characteristics of safety, convenience, and cross “fiat-crypto”. It’s becoming popular in Southeast Asia, Europe and other regions, and in particular, has become the most popular platform for novice crypto investors in Indonesia. Meanwhile, Bit.Store is focused on enhancing its attribute for social networking, ready to fully embrace the web3.0 era, helping novice users build a decentralized community, and establish efficient information exchange channels for digital assets.
Briefly, through Bit.Store platform, novice investors can directly buy cryptos with fiats, for instance, buying USDT or BTC with U.S. dollars. And there is no need to worry about security and legal issues, which will be specifically referred to in the following.
As a matter of fact, in this field, there are already many competitors. In the present business environment, where there are people, there will be always competition. Apparently, PayPal and CashApp are outstanding ones in the sector. However, it is undeniable that they also have defects. For example, PayPal purchases bitcoins. The handling fee of 2%-5% is rarely mentioned by CashApp in the Asian region. Complicated operation procedures, long waiting confirmation time, asset-light publicity coverage, high handling fees, etc., are all the obstacles that keep users from entering the field of digital currency investment, thus slow down the expanding of digital currency that was originally meant to improve asset utilization and efficiency.
Before the launch of Bit.Store, we have done sufficient research on the market and optimized all these problems.
Handling fee: Bit.Store charges only 2% handling fee.
Operation: Once you have the actual experience on Bit.Store, you will find that there are only three steps to go through when buying bitcoin, namely, check the transaction curve of the price, choose to buy, choose the payment method, and there you go. No matter you’re a novice or veteran user, you can enjoy the ultimate experience.
Security: Bit.Store’s assets are entrusted to Coinbase, one of the world’s top three trading platforms, and Cobo, Asia’s leading cryptocurrency wallet, which should be familiar to longtime users. Coinbase, in particular, is the dominant trading platform right now. In addition to selecting reliable partners, Bit.Store also invites PWC auditors to conduct regular audits, which, combined with its active compliance with laws and regulations, makes Bit.Store’s security level almost equal to that of asset managers in traditional finance.
Development Plan: The history of Nokia tells us that if we do not move forward, we will be abandoned by the time. This is especially true in the domain of blockchain. As a result of the rapidly changing market and industry hit, we must stay humble and stay hungry, if we want to achieve long-term growth. In this regard, Bit.Store is not only a fiat trading platform, but also a UGC/PGC community, which can be envisaged as the Bilibili.com in the field of digital currency. Users can freely discuss issues about cryptos and help beginners understand investment skills. Blockchain is based on consensus and trust, which is also implemented by Bit.Store as a core guidance. Of course, there will be incentives for referrals and those who are active in answering questions in the community.
Only with a solid foundation we can have a bright future
Similar to PayPal, Alipay is very popular in China, while almost everyone has an account of PayPal in Europe and America. In Southeast Asia, where Bit.Store is well accepted, it becomes a promising region. Especially in recent years, due to geographical location and development advantages, Southeast Asia shows a tendency of increasingly expanding young population. Young people tend to accept new things due to their curiosity. According to a survey, it shows that 80% of the respondents said they were aware of cryptocurrency, 53% expressed the interest to invest, 17% of them are even very knowledgeable about cryptos.
Thanks to the huge number of young people, it has laid a good foundation for Bit.Store’s business expansion and development. In addition, the regulatory environment in Southeast Asia is also very friendly, with well-established channels. At the same time, it is also sophisticated for international communication in the region. Although it is slightly less developed than Europe and the United States, but as for the internet infrastructure and its leading economic basis, users in Southeast Asia tend to be more open towards cryptocurrencies.
It is noted that successful transactions between fiat and crypto currencies often require more than just users and technology. The factor of government relations is often the most important element. It is understood that Bit.Store attaches much more importance to this area than what you can imagine. The cooperation has been rolled out with nearly 40 payment companies in over 20 countries and regions, with one international bank and one international payment institution. Right now there are payment licenses available in Hong Kong, the Philippines, Singapore, as well as many countries and regions in the European Union.
According to official data, Bit.Store has already attracted 200,000 users worldwide since its launch about a year ago, with some 50,000 daily active users. The sharp increase in the number of users shows that there is a looming demand in the market in this area, and the surge in growth should be due to its full preparation. In the aspect of social functions, as mentioned above, it is an important part of Bit.Store’s development plan. In the traditional world, money and information are transferred separately, while in the blockchain world, value and information are combined. There is no doubt that trust is a must. With a brand-new business module, we have the widest economic moat to make the service to be adored and recognized by users.
Bitcoin was created about 10 years ago. However, in those days no one could imagine that the value of Bitcoin would reach 60,000 US dollars ten years later. In this sense, the future always means something you can’t imagine. Nowadays, Bitcoin is no longer a topic discussed in a small circle. Bitcoin and other digital currencies have got their best chance to grow, thus they have become a rising star in the global investment field. At the same time, blockchain technology has also been on the top of the R&D agenda in many countries.
Probably some people are still watching, while some people have already quit. Perhaps some people are eager to get started, while some people get frustrated about it. In any case, the future development is bound to go forward. And if you didn’t find a way to get onboard the bandwagon, then hop on Bit.Store.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Nova Junk, a family-owned junk removal company based in Alexandria, Virginia, celebrates two decades of responsible hauling, recycling, and donation services across the Washington DC metro region.
Washington, United States, 16th Jul 2026 – Nova Junk, a locally owned junk removal company serving Washington, DC, Northern Virginia, and Maryland, is marking its 20th year in business. Founded on September 11, 2005, according to information published on the company website, the company has grown from a two-person family operation into a multi-service hauling company with a team that includes extended family members and long-tenured employees.
Nova Junk provides junk removal, estate cleanouts, office cleanouts, construction debris removal, yard debris hauling, shed removal, hot tub disposal, and labor-only services, according to the company website. The company serves communities throughout the Washington DC metro area, including Alexandria, Fairfax, Arlington, Bethesda, Montgomery County, and Prince George County.
A distinguishing feature of Nova Junk’s operating model is its three-stage disposal process: donate, recycle, and landfill. According to information published on the company website, the team sorts through all collected material, first setting aside items that can be donated to local charities and then separating recyclable materials such as batteries, printers, and refrigerators. Only the remainder goes to the landfill, and the company states that it typically sends just one third of collected material to the dump.
The company is licensed and fully insured, according to the company website, and places a strong emphasis on punctuality and transparent pricing. Nova Junk states that final charges are adjusted downward when a load turns out to be smaller than estimated, a policy highlighted repeatedly in customer reviews published on the company website.
“We started this company as a family and grew it the same way – by treating every customer’s home and business the way we would want ours treated,” said Norman Elbekri, Co-founder at Nova Junk. “After 20 years we are still committed to the same values we started with: honest pricing, responsible disposal, and service that people can count on.”
Nova Junk serves both residential and commercial clients. Services extend to de-cluttering and hoarding solutions, moving and foreclosure cleanouts, and demolition site cleanup. The company operates from two locations – 2000 Duke Street in Alexandria, Virginia and Smoketown Road in Woodbridge, Virginia – and can be reached at novajunk.com.
About Nova Junk
Nova Junk is a family-owned junk removal company founded in 2005, serving Washington, DC, Northern Virginia, and Maryland. The company provides residential and commercial hauling, estate cleanouts, construction debris removal, and specialty services including shed and hot tub removal. Nova Junk is committed to responsible disposal through a donate-recycle-landfill approach that minimizes landfill impact. Learn more at https://www.novajunk.com
Media Contact
Organization: Nova Junk
Contact Person: Norman Elbekri Co-founder
Website: https://www.novajunk.com/
Email:
info@novajunk.com
City: Washington
Country:United States
Release id:47175
The post Nova Junk marks 20 years of eco-friendly junk removal in the Washington DC area appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Jyong Biotech has updated its market entry strategy for innovative botanical pharmaceuticals, establishing multiple competitive advantages for its new drug portfolio
Jyong Biotech Ltd. (Nasdaq stock code: MENS) (hereinafter referred to as “the Company” or “Jyong Biotech”) is a science-driven biotechnology company dedicated to developing and commercializing innovative plant-based therapies. The Company recently announced that, following an analysis of the clinical efficacy and competitive advantages of its innovative botanical drugs Botreso® and PCP, it has advanced its market access strategy.
As previously announced by the company, its first core product, Botreso®, has completed four Phase III clinical trials (API-1) in the United States and Taiwan, while its second core product, PCP, has successfully completed a Phase II clinical trial. Overall clinical data demonstrate that Jyong Biotech’s innovative botanical drugs exhibit significant differentiation advantages compared to currently marketed synthetic chemical drugs.
Overall Safety Profile for Long-Term Use
For middle-aged and elderly males requiring long-term medication, safety is one of the most decisive factors. In clinical trials—Botreso® (Phase III) had a treatment duration of one year, while PCP (Phase II) lasted two years—no drug-related serious adverse events were observed, demonstrating excellent safety and tolerability.
In contrast, currently available chemically synthesized drugs for the treatment of benign prostatic hyperplasia (BPH) are often associated with adverse effects such as postural hypotension, erectile dysfunction, and decreased libido. Regulatory authorities and research institutions have linked certain synthetic alternative medications to significant risks, prompting the U.S. Food and Drug Administration (FDA) to issue a safety advisory regarding advanced prostate cancer and depression in 2011, and to include suicidal ideation in its list of adverse reactions in 2022. Additionally, an independent study conducted in 2021 also established associations between these drugs and cardiac failure.
Management of risks associated with advanced prostate cancer
Large-scale international clinical trials have demonstrated that while certain synthetic drugs used to treat benign prostatic hyperplasia (BPH) can reduce the overall incidence of prostate cancer, they may paradoxically increase the proportion of advanced prostate cancer (Grisson score ≥ 7) when cancer develops, thereby posing significant clinical safety concerns.
The Phase II clinical trial of PCP was a large-scale, long-term study on rare conditions conducted in Taiwan across 20 major hospitals. Over a period of two years, the trial involved 135 urologists (representing more than one-tenth of all urologists in Taiwan) and enrolled a total of 702 participants. It was one of the first global clinical trials specifically targeting prostate cancer prevention using a novel botanical drug conducted in Taiwan. The results demonstrated that PCP exhibited a downward trend in both overall prostate cancer incidence and the risk of advanced-stage prostate cancer, effectively addressing concerns within the medical community regarding the risks associated with existing therapies.
Comprehensive approach of “Treatment + Prevention + Metabolic Management”
Based on the clinical data from the company’s conducted trials, the company believes it is establishing a differentiated product positioning.
• Improvement of lower urinary tract symptoms (LUTS): Effectively alleviates symptoms associated with benign prostatic hyperplasia.
• Prevention of prostate cancer: Demonstrates prophylactic clinical potential.
• Metabolic and cardiovascular protection: Decreased triglyceride levels (P=0.05), significantly reduced total cholesterol and low-density lipoprotein (bad cholesterol) (P<0.05), significantly increased high-density lipoprotein (good cholesterol) (P<0.05), and maintained stable blood glucose levels.
This comprehensive therapy delivers benefits without adversely affecting blood pressure, liver function, or renal function. The company emphasizes that this integrated approach combining treatment, prevention, and metabolic management is exceptionally rare among current prostate medications and holds significant appeal for men aged 40 and above.
Technical Barriers and Competitive Advantages
Due to the inherent complexity and diversity of components in novel botanical drugs, quality control poses greater challenges compared to that of small-molecule chemical drugs. Jianyong Biotechnology asserts that the company has successfully established a comprehensive technical platform, which includes:
• Purification and establishment of reference standards.
• Development and validation of analytical methods.
• Perform the validation analysis and verification process.
The company believes that such comprehensive capabilities create substantial market entry barriers, rendering the products highly difficult to replicate. Furthermore, they effectively mitigate risks associated with competition from counterfeit and substandard products as well as generic drugs, ultimately contributing to an extended period of market monopoly.
The upgraded market positioning and strategic value
As a plant-based new drug protected by global patents, Jyong Biotech believes its market strategy leverages the following key advantages:
• Pricing competitiveness: Its unique metabolic protection profile and safety profile enable it to command higher prices compared to non-patented generic drugs, making it attractive to both out-of-pocket and high-end healthcare markets.
• Authorization potential: The combination of high tolerability, excellent safety profile (no serious adverse reactions), and multiple clinical benefits makes it an ideal target for international pharmaceutical collaboration.
• Market scalability: Expanding the product portfolio from treatment-oriented approaches to the fields of preventive medicine and health management.
Globally, over 500 million men aged 50 and above seek treatment for benign prostatic hyperplasia (BPH). In 2020, the global BPH drug market was valued at $4.1 billion and is projected to reach $9.8 billion by 2026. Although the current treatment market generates annual revenues of approximately $6.5 to $7 billion, this figure reflects price reductions due to patent expiration. If calculated based on prices during the patent period, the market potential exceeds $20 billion annually.
“Due to the complex composition of botanical new drugs, they face significant challenges in quality control compared to small-molecule chemical drugs,” stated Chairman Guo of Jianyong Biotechnology. “We have established a robust technical platform that encompasses the purification of reference standards, development and validation of analytical methods, as well as performance validation analyses. This high entry barrier makes counterfeiting difficult to achieve, reduces competition from generic drugs, and helps extend market exclusivity periods.”
Chairman Guo stated: “Botreso® is Taiwan’s first oral botanical drug to obtain an IND approval from the U.S. FDA for Phase III clinical trials (API-1) and has successfully completed all four Phase III clinical trials.”
Jyong Biotech holds multiple invention patents across Asia, the Americas, and the European Union, and has signed letters of intent and investment agreements with several international pharmaceutical companies. The company plans to further expand its strategic, fee-based licensing partnerships to support its global market expansion.
As of today, Botreso® and PCP remain in the investigational new drug candidate stage and have not yet been approved for commercial use in any jurisdiction. Jyong Biotech will comply with applicable regulatory disclosure obligations and provide timely, accurate, and complete updates on significant progress.
Company Profile: Jyong Biotech Ltd., headquartered in Taiwan, is a science-driven biotechnology company dedicated to the research, development, and commercialization of innovative and differentiated novel drugs (of plant origin), with a primary focus on the treatment of urinary system disorders, initially targeting the markets in the United States, the European Union, and Asia. Since its establishment in 2002, the company has developed comprehensive capabilities encompassing all critical stages of drug development, including early-stage drug discovery and development, pharmacology, toxicology, clinical trials, regulatory affairs, manufacturing, and commercialization. Leveraging robust R&D capabilities and proprietary platforms, the company has developed a portfolio of plant-derived candidate drugs, including its lead plant-based candidate Botreso®, another plant-based candidate drug in clinical development, and several other plant-based candidates in preclinical stages. The company is committed to developing and delivering cutting-edge innovative therapeutics to address customer health needs and strives to become a respected and valuable enterprise.
For more information, please contact:
Jyong Biotech Ltd.
ir@jyongbio.com
Investor Relations Department
WFS Investor Relations Inc.
Mailbox: services@wfsir.com
Phone: +1628 283 9214
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Experience the Future of Urban Mobility Firsthand: Tarran Presents the New L1 Series at Eurobike 2026
United States, 16th Jul 2026, – As the global cycling industry gathers in Frankfurt from June 24 to 27, 2026, TARRAN will exhibit at Booth F12 B26, where the company will debut the new L1 Series alongside its flagship model, the T1 Pro. Visitors can experience both models firsthand at the booth.
Following last year’s market launch of the T1 Pro, Tarran is expanding its portfolio, combining engineering precision with the demands of everyday urban riding.
Featured Models
L1 Series: New for 2026
The new model is engineered for practical everyday use. As TARRAN’s first intelligent longtail cargo bike designed for families, its core innovations include the industry-first SyncStand Auto, an electronic kickstand that parks the bike at the push of a button, and an E-Dropper Post that adjusts saddle height instantly.
Paired with Enviolo AUTOMATIQ Pro automatic shifting, fully integrated into TarranOS, the L1 delivers an intuitive, low-effort riding experience. It features a 100 Nm mid-drive motor, a removable 693 Wh battery built with Samsung cells, and a reinforced longtail frame supporting a maximum gross vehicle weight of 215 kg (474 lb).
For rider and passenger safety, the Vision Unit—combining a rear-view camera and mmWave radar—works together with integrated front and rear turn signals to provide 360-degree protection for the whole family. TARRAN continuously improves the L1 through over-the-air updates, supporting long-term product maintenance and ongoing refinement. A firmware update scheduled for late June will add native control for DJI action cameras and an anti-pinch safety function for the electronic kickstand.
T1 Pro
Successfully launched last year, the flagship model continues to demonstrate the brand’s technological strengths. The T1 Pro is equipped with active safety systems that monitor the bike’s surroundings and assist the rider in critical situations.
The T1 Pro features Tarran’s proprietary Dynamic Dualdrive landing gear, which stabilizes the bike while riding and at a standstill, reducing the risk of tipping. It is designed to carry families with two to three children in comfort, while its compact 2.26-meter (7.4 ft) overall length ensures agile handling.
Putting the Riding Experience First
Tarran believes that genuine innovation is best understood through direct experience. While the exhibit offers a closer look at the underlying technical architecture, consumers and e-bike enthusiasts are welcome to test ride both models directly at the TARRAN booth.
Visitors can see for themselves how the intuitive controls and safety features change the riding experience in urban environments.
Global Growth and Dealer Network
Reflecting TARRAN’s continued growth, and with the L1 Series now in series production, the brand’s products are available in more than 100 retail stores worldwide.
Strengthening its global footprint, TARRAN is now formally entering the North American market, actively building a dealer network across the United States and Canada to bring its intelligent, safety-focused cargo bikes to more families.
Expert Dialogue and Consultations
Tarran offers trade journalists and partners the opportunity for individual, in-depth background briefings. On-site experts will be available in the following areas:
Product Development and Technology: Shiyuan, Product Manager.
Strategy and Marketing: Dennis Wang and Larry Hu.
DACH Region Sales: Sebastian Locher and Jiaming Lee.
Benelux Region Sales: Fabian Hard.
Press Contact and Scheduling: To arrange a briefing or a test ride, please contact tarran@laika.berlin.
About TARRAN
Founded in 2023, TARRAN develops human-centered mobility experiences that combine clean energy with intelligent systems, with the goal of accelerating the transition to a more sustainable future.
The team draws on experience from leading technology companies, including DJI, and believes that technology can help solve real-world challenges while making a positive contribution to the world we live in.
TARRAN currently operates across three locations: Dusseldorf, Hong Kong, and Shenzhen. Its research, development, and testing center is located in Shenzhen, while its manufacturing hubs are situated in Europe and Southeast Asia.
Media Contact
Organization: Tarran GmbH
Contact
Person: Media Relations
Website:
https://tarranbikes.com/
Email:
store@tarranbikes.com
Contact Number: 8618898353598
Country:United States
The post
Experience the Future of Urban Mobility Firsthand: Tarran Presents the New L1 Series at Eurobike 2026 appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Nova Junk marks 20 years of eco-friendly junk removal in the Washington DC area
Jyong Biotech has updated its market entry strategy for innovative botanical pharmaceuticals, establishing multiple competitive advantages for its new drug portfolio
Experience the Future of Urban Mobility Firsthand: Tarran Presents the New L1 Series at Eurobike 2026
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release1 week ago
Vincere Portfolios Highlights Growing Shift Toward Algorithmic Futures Trading Among Independent Investors
-
Press Release5 days ago
Thriving in Retirement Michael Masor’s Newly Released Book is a Complete Blueprint for Modern Retirement Planning
-
Press Release6 days ago
SK Hynix ETFs – 2x Long (SKHX) & 1x Short (SKHZ) from Leverage Shares by Themes Arrive as ADRs Begin Trading
-
Press Release5 days ago
Ruckaroo Launches World’s First Fitness App Built for Weighted Walking
-
Press Release5 days ago
New Guide Helps Musicians Create a Connected Music Marketing System
-
Press Release6 days ago
Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care
-
Press Release5 days ago
JDLINO BRAND & FELITWO Celebrating El Champ — The Feroz Vargas and His Familión: A New Era in Boxing Power
-
Press Release5 days ago
Northlake Concierge Medical Center Announces Boutique Class-A Medical Office Development in Tucker, Georgia